HEADER HYDROLASE 13-MAY-03 1OGS TITLE HUMAN ACID-BETA-GLUCOSIDASE CAVEAT 1OGS NAG A 1997 HAS WRONG CHIRALITY AT ATOM C1 NAG A 1997 WRONG CAVEAT 2 1OGS HAND AT C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUCOSYLCERAMIDASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ACID BETA-GLUCOSIDASE,ALGLUCERASE,BETA-GLUCOCEREBROSIDASE, COMPND 5 BETA-GC,D-GLUCOSYL-N-ACYLSPHINGOSINE GLUCOHYDROLASE,IMIGLUCERASE; COMPND 6 EC: 3.2.1.45,2.4.1.-,3.2.1.104; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GBA, GC, GLUC; SOURCE 6 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10029; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: CHO KEYWDS HYDROLASE, GAUCHER DISEASE, GLUCOSIDASE, GLUCOCEREBROSIDASE, CEREZYME KEYWDS 2 HYDROLASE, GLYCOSIDASE, SPHINGOLIPID METABOLISM, GLYCOPROTE KEYWDS 3 LYSOSOME, MEMBRANE, DISEASE MUTATI POLYMORPHISM, ALTERNATIVE KEYWDS 4 INITIATION, PHARMACEUTICAL, ISRAEL STRUCTURAL PROTEOMICS CENTER, KEYWDS 5 ISPC, STRUCTURAL GENOMICS EXPDTA X-RAY DIFFRACTION AUTHOR H.DVIR,M.HAREL,A.A.MCCARTHY,L.TOKER,I.SILMAN,A.H.FUTERMAN,J.L.SUSSMAN REVDAT 7 20-NOV-24 1OGS 1 HETSYN REVDAT 6 29-JUL-20 1OGS 1 CAVEAT COMPND REMARK HETNAM REVDAT 6 2 1 LINK SITE ATOM REVDAT 5 16-OCT-19 1OGS 1 COMPND SOURCE REMARK DBREF REVDAT 5 2 1 SEQADV LINK REVDAT 4 25-JAN-12 1OGS 1 CAVEAT REMARK VERSN HET REVDAT 4 2 1 HETNAM FORMUL HETSYN LINK REVDAT 4 3 1 SITE HETATM REVDAT 3 24-FEB-09 1OGS 1 VERSN REVDAT 2 21-OCT-03 1OGS 1 REMARK REVDAT 1 03-JUL-03 1OGS 0 JRNL AUTH H.DVIR,M.HAREL,A.A.MCCARTHY,L.TOKER,I.SILMAN,A.H.FUTERMAN, JRNL AUTH 2 J.L.SUSSMAN JRNL TITL X-RAY STRUCTURE OF HUMAN ACID-BETA-GLUCOSIDASE, THE JRNL TITL 2 DEFECTIVE ENZYME IN GAUCHER DISEASE JRNL REF EMBO REP. V. 4 704 2003 JRNL REFN ISSN 1469-221X JRNL PMID 12792654 JRNL DOI 10.1038/SJ.EMBOR.EMBOR873 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 14.40 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.3 REMARK 3 NUMBER OF REFLECTIONS : 88501 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.300 REMARK 3 FREE R VALUE TEST SET COUNT : 4690 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.003 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.13 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 81.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 12234 REMARK 3 BIN R VALUE (WORKING SET) : 0.3010 REMARK 3 BIN FREE R VALUE : 0.3100 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 662 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.012 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7859 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 117 REMARK 3 SOLVENT ATOMS : 938 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 17.24000 REMARK 3 B22 (A**2) : -8.15000 REMARK 3 B33 (A**2) : -9.09000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.22 REMARK 3 ESD FROM SIGMAA (A) : 0.32 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.31 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.860 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.210 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.900 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.950 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.840 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.39 REMARK 3 BSOL : 69.07 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : CARBOHYDRATE.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1OGS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 13-MAY-03. REMARK 100 THE DEPOSITION ID IS D_1290012718. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-MAR-03 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 4.60 REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0092, 1.0075, 1.0015, 0.8856 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 93248 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 10.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : 10.00 REMARK 200 R MERGE (I) : 0.06500 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 21.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.10 REMARK 200 COMPLETENESS FOR SHELL (%) : 84.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.37000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.230 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: VAPOUR DIFFUSION AT ROOM TEMP DROP REMARK 280 CONTAINS 1.5 MICROLITER OF PROTEIN SOLUTION (10MG/ML) AND 1.5 REMARK 280 MICROLITER OF MOTHER LIQUOR. MOTHER LIQUOR CONTAINS 1M AMMONIUM REMARK 280 SULFATE, 0.17M GUANIDINE HYDROCHLORIDE, 0.02M KCL, 0.1M ACETATE REMARK 280 PH 4.6., PH 4.60, VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.83900 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 45.83900 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 53.86750 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 142.61600 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 53.86750 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 142.61600 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 45.83900 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 53.86750 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 142.61600 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 45.83900 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 53.86750 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 142.61600 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B2013 LIES ON A SPECIAL POSITION. REMARK 375 HOH B2209 LIES ON A SPECIAL POSITION. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NE2 GLN A 226 O HOH A 2238 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 49 53.20 37.42 REMARK 500 PHE A 75 -139.79 -126.44 REMARK 500 ALA A 124 -153.88 79.85 REMARK 500 PHE A 128 56.49 -90.73 REMARK 500 TYR A 133 155.56 175.74 REMARK 500 ASP A 140 71.74 31.85 REMARK 500 LEU A 156 -69.66 -104.16 REMARK 500 ASN A 192 -157.29 -128.36 REMARK 500 GLU A 233 144.68 162.37 REMARK 500 GLU A 235 68.26 37.52 REMARK 500 ASP A 263 -70.34 -119.01 REMARK 500 LEU A 281 -81.85 71.18 REMARK 500 ALA A 318 118.48 -160.11 REMARK 500 THR A 323 -74.78 -103.27 REMARK 500 HIS A 374 -1.56 72.18 REMARK 500 TRP A 381 -139.37 -84.82 REMARK 500 ARG A 395 141.68 179.28 REMARK 500 PHE A 397 -8.79 -151.89 REMARK 500 PHE B 75 -139.05 -124.03 REMARK 500 ALA B 124 -155.97 80.87 REMARK 500 LEU B 156 -70.87 -116.20 REMARK 500 ASN B 192 -167.48 -117.63 REMARK 500 GLU B 233 139.97 166.77 REMARK 500 GLU B 235 66.54 34.43 REMARK 500 ASP B 263 -71.23 -114.50 REMARK 500 LEU B 281 -76.15 67.75 REMARK 500 THR B 323 -76.46 -103.60 REMARK 500 HIS B 374 -5.84 76.46 REMARK 500 TRP B 381 -138.35 -82.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2017 DISTANCE = 6.58 ANGSTROMS REMARK 525 HOH A2061 DISTANCE = 7.17 ANGSTROMS REMARK 525 HOH A2076 DISTANCE = 6.47 ANGSTROMS REMARK 525 HOH B2057 DISTANCE = 6.51 ANGSTROMS REMARK 525 HOH B2060 DISTANCE = 6.68 ANGSTROMS REMARK 525 HOH B2076 DISTANCE = 6.19 ANGSTROMS REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: DSSP REMARK 700 THE SHEETS PRESENTED AS "AC" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 8-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 9-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. REMARK 700 THE SHEETS PRESENTED AS "BC" IN EACH CHAIN ON SHEET RECORDS REMARK 700 BELOW IS ACTUALLY AN 8-STRANDED BARREL THIS IS REPRESENTED BY REMARK 700 A 9-STRANDED SHEET IN WHICH THE FIRST AND LAST STRANDS REMARK 700 ARE IDENTICAL. DBREF 1OGS A 1 497 UNP P04062 GLCM_HUMAN 40 536 DBREF 1OGS B 1 497 UNP P04062 GLCM_HUMAN 40 536 SEQADV 1OGS HIS A 495 UNP P04062 ARG 534 CONFLICT SEQADV 1OGS HIS B 495 UNP P04062 ARG 534 CONFLICT SEQRES 1 A 497 ALA ARG PRO CYS ILE PRO LYS SER PHE GLY TYR SER SER SEQRES 2 A 497 VAL VAL CYS VAL CYS ASN ALA THR TYR CYS ASP SER PHE SEQRES 3 A 497 ASP PRO PRO THR PHE PRO ALA LEU GLY THR PHE SER ARG SEQRES 4 A 497 TYR GLU SER THR ARG SER GLY ARG ARG MET GLU LEU SER SEQRES 5 A 497 MET GLY PRO ILE GLN ALA ASN HIS THR GLY THR GLY LEU SEQRES 6 A 497 LEU LEU THR LEU GLN PRO GLU GLN LYS PHE GLN LYS VAL SEQRES 7 A 497 LYS GLY PHE GLY GLY ALA MET THR ASP ALA ALA ALA LEU SEQRES 8 A 497 ASN ILE LEU ALA LEU SER PRO PRO ALA GLN ASN LEU LEU SEQRES 9 A 497 LEU LYS SER TYR PHE SER GLU GLU GLY ILE GLY TYR ASN SEQRES 10 A 497 ILE ILE ARG VAL PRO MET ALA SER CYS ASP PHE SER ILE SEQRES 11 A 497 ARG THR TYR THR TYR ALA ASP THR PRO ASP ASP PHE GLN SEQRES 12 A 497 LEU HIS ASN PHE SER LEU PRO GLU GLU ASP THR LYS LEU SEQRES 13 A 497 LYS ILE PRO LEU ILE HIS ARG ALA LEU GLN LEU ALA GLN SEQRES 14 A 497 ARG PRO VAL SER LEU LEU ALA SER PRO TRP THR SER PRO SEQRES 15 A 497 THR TRP LEU LYS THR ASN GLY ALA VAL ASN GLY LYS GLY SEQRES 16 A 497 SER LEU LYS GLY GLN PRO GLY ASP ILE TYR HIS GLN THR SEQRES 17 A 497 TRP ALA ARG TYR PHE VAL LYS PHE LEU ASP ALA TYR ALA SEQRES 18 A 497 GLU HIS LYS LEU GLN PHE TRP ALA VAL THR ALA GLU ASN SEQRES 19 A 497 GLU PRO SER ALA GLY LEU LEU SER GLY TYR PRO PHE GLN SEQRES 20 A 497 CYS LEU GLY PHE THR PRO GLU HIS GLN ARG ASP PHE ILE SEQRES 21 A 497 ALA ARG ASP LEU GLY PRO THR LEU ALA ASN SER THR HIS SEQRES 22 A 497 HIS ASN VAL ARG LEU LEU MET LEU ASP ASP GLN ARG LEU SEQRES 23 A 497 LEU LEU PRO HIS TRP ALA LYS VAL VAL LEU THR ASP PRO SEQRES 24 A 497 GLU ALA ALA LYS TYR VAL HIS GLY ILE ALA VAL HIS TRP SEQRES 25 A 497 TYR LEU ASP PHE LEU ALA PRO ALA LYS ALA THR LEU GLY SEQRES 26 A 497 GLU THR HIS ARG LEU PHE PRO ASN THR MET LEU PHE ALA SEQRES 27 A 497 SER GLU ALA CYS VAL GLY SER LYS PHE TRP GLU GLN SER SEQRES 28 A 497 VAL ARG LEU GLY SER TRP ASP ARG GLY MET GLN TYR SER SEQRES 29 A 497 HIS SER ILE ILE THR ASN LEU LEU TYR HIS VAL VAL GLY SEQRES 30 A 497 TRP THR ASP TRP ASN LEU ALA LEU ASN PRO GLU GLY GLY SEQRES 31 A 497 PRO ASN TRP VAL ARG ASN PHE VAL ASP SER PRO ILE ILE SEQRES 32 A 497 VAL ASP ILE THR LYS ASP THR PHE TYR LYS GLN PRO MET SEQRES 33 A 497 PHE TYR HIS LEU GLY HIS PHE SER LYS PHE ILE PRO GLU SEQRES 34 A 497 GLY SER GLN ARG VAL GLY LEU VAL ALA SER GLN LYS ASN SEQRES 35 A 497 ASP LEU ASP ALA VAL ALA LEU MET HIS PRO ASP GLY SER SEQRES 36 A 497 ALA VAL VAL VAL VAL LEU ASN ARG SER SER LYS ASP VAL SEQRES 37 A 497 PRO LEU THR ILE LYS ASP PRO ALA VAL GLY PHE LEU GLU SEQRES 38 A 497 THR ILE SER PRO GLY TYR SER ILE HIS THR TYR LEU TRP SEQRES 39 A 497 HIS ARG GLN SEQRES 1 B 497 ALA ARG PRO CYS ILE PRO LYS SER PHE GLY TYR SER SER SEQRES 2 B 497 VAL VAL CYS VAL CYS ASN ALA THR TYR CYS ASP SER PHE SEQRES 3 B 497 ASP PRO PRO THR PHE PRO ALA LEU GLY THR PHE SER ARG SEQRES 4 B 497 TYR GLU SER THR ARG SER GLY ARG ARG MET GLU LEU SER SEQRES 5 B 497 MET GLY PRO ILE GLN ALA ASN HIS THR GLY THR GLY LEU SEQRES 6 B 497 LEU LEU THR LEU GLN PRO GLU GLN LYS PHE GLN LYS VAL SEQRES 7 B 497 LYS GLY PHE GLY GLY ALA MET THR ASP ALA ALA ALA LEU SEQRES 8 B 497 ASN ILE LEU ALA LEU SER PRO PRO ALA GLN ASN LEU LEU SEQRES 9 B 497 LEU LYS SER TYR PHE SER GLU GLU GLY ILE GLY TYR ASN SEQRES 10 B 497 ILE ILE ARG VAL PRO MET ALA SER CYS ASP PHE SER ILE SEQRES 11 B 497 ARG THR TYR THR TYR ALA ASP THR PRO ASP ASP PHE GLN SEQRES 12 B 497 LEU HIS ASN PHE SER LEU PRO GLU GLU ASP THR LYS LEU SEQRES 13 B 497 LYS ILE PRO LEU ILE HIS ARG ALA LEU GLN LEU ALA GLN SEQRES 14 B 497 ARG PRO VAL SER LEU LEU ALA SER PRO TRP THR SER PRO SEQRES 15 B 497 THR TRP LEU LYS THR ASN GLY ALA VAL ASN GLY LYS GLY SEQRES 16 B 497 SER LEU LYS GLY GLN PRO GLY ASP ILE TYR HIS GLN THR SEQRES 17 B 497 TRP ALA ARG TYR PHE VAL LYS PHE LEU ASP ALA TYR ALA SEQRES 18 B 497 GLU HIS LYS LEU GLN PHE TRP ALA VAL THR ALA GLU ASN SEQRES 19 B 497 GLU PRO SER ALA GLY LEU LEU SER GLY TYR PRO PHE GLN SEQRES 20 B 497 CYS LEU GLY PHE THR PRO GLU HIS GLN ARG ASP PHE ILE SEQRES 21 B 497 ALA ARG ASP LEU GLY PRO THR LEU ALA ASN SER THR HIS SEQRES 22 B 497 HIS ASN VAL ARG LEU LEU MET LEU ASP ASP GLN ARG LEU SEQRES 23 B 497 LEU LEU PRO HIS TRP ALA LYS VAL VAL LEU THR ASP PRO SEQRES 24 B 497 GLU ALA ALA LYS TYR VAL HIS GLY ILE ALA VAL HIS TRP SEQRES 25 B 497 TYR LEU ASP PHE LEU ALA PRO ALA LYS ALA THR LEU GLY SEQRES 26 B 497 GLU THR HIS ARG LEU PHE PRO ASN THR MET LEU PHE ALA SEQRES 27 B 497 SER GLU ALA CYS VAL GLY SER LYS PHE TRP GLU GLN SER SEQRES 28 B 497 VAL ARG LEU GLY SER TRP ASP ARG GLY MET GLN TYR SER SEQRES 29 B 497 HIS SER ILE ILE THR ASN LEU LEU TYR HIS VAL VAL GLY SEQRES 30 B 497 TRP THR ASP TRP ASN LEU ALA LEU ASN PRO GLU GLY GLY SEQRES 31 B 497 PRO ASN TRP VAL ARG ASN PHE VAL ASP SER PRO ILE ILE SEQRES 32 B 497 VAL ASP ILE THR LYS ASP THR PHE TYR LYS GLN PRO MET SEQRES 33 B 497 PHE TYR HIS LEU GLY HIS PHE SER LYS PHE ILE PRO GLU SEQRES 34 B 497 GLY SER GLN ARG VAL GLY LEU VAL ALA SER GLN LYS ASN SEQRES 35 B 497 ASP LEU ASP ALA VAL ALA LEU MET HIS PRO ASP GLY SER SEQRES 36 B 497 ALA VAL VAL VAL VAL LEU ASN ARG SER SER LYS ASP VAL SEQRES 37 B 497 PRO LEU THR ILE LYS ASP PRO ALA VAL GLY PHE LEU GLU SEQRES 38 B 497 THR ILE SER PRO GLY TYR SER ILE HIS THR TYR LEU TRP SEQRES 39 B 497 HIS ARG GLN MODRES 1OGS ASN A 19 ASN GLYCOSYLATION SITE MODRES 1OGS ASN B 19 ASN GLYCOSYLATION SITE HET NAG C 1 14 HET NAG C 2 14 HET SO4 A1498 5 HET SO4 A1499 5 HET SO4 A1500 5 HET SO4 A1501 5 HET SO4 A1502 5 HET SO4 A1503 5 HET SO4 A1504 5 HET SO4 A1505 5 HET SO4 A1506 5 HET SO4 A1507 5 HET NAG A1997 14 HET SO4 B1498 5 HET SO4 B1499 5 HET SO4 B1500 5 HET SO4 B1501 5 HET SO4 B1502 5 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM SO4 SULFATE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 NAG 3(C8 H15 N O6) FORMUL 4 SO4 15(O4 S 2-) FORMUL 20 HOH *938(H2 O) HELIX 1 1 THR A 86 LEU A 94 1 9 HELIX 2 2 SER A 97 SER A 110 1 14 HELIX 3 3 PRO A 150 LYS A 155 1 6 HELIX 4 4 LEU A 156 ALA A 168 1 13 HELIX 5 5 PRO A 182 LEU A 185 5 4 HELIX 6 6 ASP A 203 HIS A 223 1 21 HELIX 7 7 SER A 237 LEU A 241 5 5 HELIX 8 8 THR A 252 ASP A 263 1 12 HELIX 9 9 ASP A 263 ASN A 270 1 8 HELIX 10 10 LEU A 286 LEU A 288 5 3 HELIX 11 11 PRO A 289 THR A 297 1 9 HELIX 12 12 ASP A 298 LYS A 303 1 6 HELIX 13 13 PRO A 319 PHE A 331 1 13 HELIX 14 14 SER A 356 TYR A 373 1 18 HELIX 15 15 ILE A 406 LYS A 408 5 3 HELIX 16 16 GLN A 414 LYS A 425 1 12 HELIX 17 17 THR B 86 ALA B 95 1 10 HELIX 18 18 SER B 97 SER B 110 1 14 HELIX 19 19 PRO B 150 LYS B 155 1 6 HELIX 20 20 LEU B 156 ALA B 168 1 13 HELIX 21 21 PRO B 182 LEU B 185 5 4 HELIX 22 22 ASP B 203 HIS B 223 1 21 HELIX 23 23 GLU B 235 LEU B 241 5 7 HELIX 24 24 THR B 252 ASP B 263 1 12 HELIX 25 25 ASP B 263 ASN B 270 1 8 HELIX 26 26 LEU B 286 LEU B 288 5 3 HELIX 27 27 PRO B 289 THR B 297 1 9 HELIX 28 28 ASP B 298 LYS B 303 1 6 HELIX 29 29 PRO B 319 PHE B 331 1 13 HELIX 30 30 SER B 356 TYR B 373 1 18 HELIX 31 31 ILE B 406 ASP B 409 5 4 HELIX 32 32 GLN B 414 LYS B 425 1 12 SHEET 1 AA 4 PRO A 6 LYS A 7 0 SHEET 2 AA 4 VAL A 15 ASN A 19 -1 O VAL A 15 N LYS A 7 SHEET 3 AA 4 THR A 410 LYS A 413 -1 O PHE A 411 N CYS A 18 SHEET 4 AA 4 ILE A 402 ASP A 405 -1 O ILE A 403 N TYR A 412 SHEET 1 AB 9 GLU A 50 PRO A 55 0 SHEET 2 AB 9 THR A 36 THR A 43 -1 O PHE A 37 N GLY A 54 SHEET 3 AB 9 SER A 488 TRP A 494 -1 O ILE A 489 N SER A 42 SHEET 4 AB 9 ALA A 456 ASN A 462 -1 O ALA A 456 N TRP A 494 SHEET 5 AB 9 LEU A 444 MET A 450 -1 O ASP A 445 N LEU A 461 SHEET 6 AB 9 GLN A 432 ALA A 438 -1 O GLN A 432 N MET A 450 SHEET 7 AB 9 LEU A 65 LYS A 77 -1 O THR A 68 N VAL A 437 SHEET 8 AB 9 VAL A 468 ASP A 474 1 O PRO A 469 N LEU A 65 SHEET 9 AB 9 GLY A 478 SER A 484 -1 O GLY A 478 N ASP A 474 SHEET 1 AC 9 GLY A 80 ALA A 84 0 SHEET 2 AC 9 VAL A 375 ASN A 382 1 O TRP A 378 N GLY A 82 SHEET 3 AC 9 MET A 335 CYS A 342 1 O LEU A 336 N VAL A 376 SHEET 4 AC 9 GLY A 307 TYR A 313 1 O ILE A 308 N PHE A 337 SHEET 5 AC 9 ARG A 277 GLN A 284 1 O MET A 280 N ALA A 309 SHEET 6 AC 9 ALA A 229 THR A 231 1 O VAL A 230 N LEU A 279 SHEET 7 AC 9 SER A 173 PRO A 178 1 O ALA A 176 N THR A 231 SHEET 8 AC 9 ILE A 118 MET A 123 1 O ILE A 119 N LEU A 175 SHEET 9 AC 9 GLY A 80 ALA A 84 1 O GLY A 83 N ARG A 120 SHEET 1 BA 4 PRO B 6 LYS B 7 0 SHEET 2 BA 4 VAL B 15 CYS B 18 -1 O VAL B 15 N LYS B 7 SHEET 3 BA 4 THR B 410 LYS B 413 -1 O PHE B 411 N CYS B 18 SHEET 4 BA 4 ILE B 402 ASP B 405 -1 O ILE B 403 N TYR B 412 SHEET 1 BB 9 GLU B 50 PRO B 55 0 SHEET 2 BB 9 THR B 36 THR B 43 -1 O PHE B 37 N GLY B 54 SHEET 3 BB 9 SER B 488 TRP B 494 -1 O ILE B 489 N SER B 42 SHEET 4 BB 9 ALA B 456 ASN B 462 -1 O ALA B 456 N TRP B 494 SHEET 5 BB 9 LEU B 444 MET B 450 -1 O ASP B 445 N LEU B 461 SHEET 6 BB 9 GLN B 432 ALA B 438 -1 O GLN B 432 N MET B 450 SHEET 7 BB 9 LEU B 65 LYS B 77 -1 O THR B 68 N VAL B 437 SHEET 8 BB 9 VAL B 468 ASP B 474 1 O PRO B 469 N LEU B 65 SHEET 9 BB 9 GLY B 478 SER B 484 -1 O GLY B 478 N ASP B 474 SHEET 1 BC 9 GLY B 80 ALA B 84 0 SHEET 2 BC 9 VAL B 375 ASN B 382 1 O TRP B 378 N GLY B 82 SHEET 3 BC 9 MET B 335 CYS B 342 1 O LEU B 336 N VAL B 376 SHEET 4 BC 9 GLY B 307 TYR B 313 1 O ILE B 308 N PHE B 337 SHEET 5 BC 9 ARG B 277 GLN B 284 1 O MET B 280 N ALA B 309 SHEET 6 BC 9 ALA B 229 THR B 231 1 O VAL B 230 N LEU B 279 SHEET 7 BC 9 SER B 173 PRO B 178 1 O ALA B 176 N THR B 231 SHEET 8 BC 9 ILE B 118 MET B 123 1 O ILE B 119 N LEU B 175 SHEET 9 BC 9 GLY B 80 ALA B 84 1 O GLY B 83 N ARG B 120 SSBOND 1 CYS A 4 CYS A 16 1555 1555 2.04 SSBOND 2 CYS A 18 CYS A 23 1555 1555 2.04 SSBOND 3 CYS B 4 CYS B 16 1555 1555 2.05 SSBOND 4 CYS B 18 CYS B 23 1555 1555 2.05 LINK ND2 ASN A 19 C1 NAG A1997 1555 1555 1.46 LINK ND2 ASN B 19 C1 NAG C 1 1555 1555 1.45 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.38 CISPEP 1 LEU A 288 PRO A 289 0 0.35 CISPEP 2 GLY A 390 PRO A 391 0 0.08 CISPEP 3 LEU B 288 PRO B 289 0 0.05 CISPEP 4 GLY B 390 PRO B 391 0 0.25 CRYST1 107.735 285.232 91.678 90.00 90.00 90.00 C 2 2 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009282 0.000000 0.000000 0.00000 SCALE2 0.000000 0.003506 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010908 0.00000